Li‐Chiu Wu
Impact in
-
- Diabetes Treatment and Management
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Diabetes Treatment and Management 6
- Diabetes Management and Research 1
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
-
- Blood Pressure and Hypertension Studies 2
- Heart Failure Treatment and Management 2
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Co-authors
- Chia‐Hsuin Chang (25 shared papers)Jou‐Wei Lin (19 shared papers)Mei‐Shu Lai (14 shared papers)Lee‐Ming Chuang (8 shared papers)K. Arnold Chan (2 shared papers)James L. Caffrey (4 shared papers)Jiun‐Ling Wang (3 shared papers)Sengwee Toh (4 shared papers)
- Journals
- Frontiers in Pharmacology (2 papers)Diabetes Obesity and Metabolism (2 papers)Journal of Hypertension (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Li‐Chiu Wu
25 papers receiving 595 citations
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 132
- Cancer Research 77
- Cardiology and Cardiovascular Medicine 112
- Hepatology 28
- Molecular Biology 224
Countries citing papers authored by Li‐Chiu Wu
This map shows the geographic impact of Li‐Chiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Chiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Chiu Wu more than expected).
Fields of papers citing papers by Li‐Chiu Wu
This network shows the impact of papers produced by Li‐Chiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Chiu Wu. The network helps show where Li‐Chiu Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Chiu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 161 | |
| 2 | 2012 | 108 | |
| 3 | 2011 | 69 | |
| 4 | 2014 | 61 | |
| 5 | 2014 | 37 | |
| 6 | 2016 | 20 | |
| 7 | 2016 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2013 | 15 | |
| 10 | 2022 | 14 | |
| 11 | 2014 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2019 | 12 | |
| 14 | 2016 | 10 | |
| 15 | 2014 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2014 | 7 | |
| 18 | 2013 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2014 | 5 |
About Li‐Chiu Wu
Li‐Chiu Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 614 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Inflammatory mediators and NSAID effects (2 papers), Blood Pressure and Hypertension Studies (2 papers), Heart Failure Treatment and Management (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Diabetes Management and Research (1 paper) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (132 citations), Cancer Research (77 citations), Cardiology and Cardiovascular Medicine (112 citations), Hepatology (28 citations) and Molecular Biology (224 citations). Li‐Chiu Wu has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chia‐Hsuin Chang, Jou‐Wei Lin, Mei‐Shu Lai, Lee‐Ming Chuang, K. Arnold Chan, James L. Caffrey, Jiun‐Ling Wang, Sengwee Toh, Fu‐Chun Chiu and Yaa‐Hui Dong. Their work appears in journals such as Frontiers in Pharmacology, Diabetes Obesity and Metabolism, Journal of Hypertension, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.